References
- Pharmaceutical and Medical Packaging News (PMPN) Magazine. [ cited 2015 Nov 16]. Available from: www.pmpnews.com/news/transdermal-delivery- market-predictedreach-315-billion-2015-pharmalive-special- report
- Alvogen launches the first generic Exelon patch in the United States. Alvogen, 2015. [ cited 2015 Sep 28]. Available from: http://www.alvogen.com/newsroom/read/alvogen-launches-the-first-generic-exelon-patch-in-the-united-states
- European Medicines Agency Rivastigmine Actavis. European Medicines Agency, 2015. [ cited 2015 Sep 28]. Available from: www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002036/human_med_001460.jsp&mid=WC0b01ac058001d124
- Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal Results From the Women’s Health Initiative Randomized Controlled Trial. J Am Med Assoc. 2002;288(3):321.
- The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701–1712.
- Canonico M, Oger E, Plu-Bureau G, et al Hormone Therapy and Venous Thromboembolism Among Postmenopausal Women: Impact of the Route of Estrogen Administration and Progestogens: the ESTHER Study. Circulation. 2007;115(7):840–845.
- Maclennan AH. Evidence-based review of therapies at the menopause. Int J Evid Based Healthc. 2009;7(2):112–123.
- Kumar V, Banga AK. Modulated iontophoretic delivery of small and large molecules through microchannels. Int J Pharm. 2012;434(1–2):106–114.
- The Medicines Company Announces FDA Approval of IONSYS® (fentanyl iontophoretic transdermal system) for the Management of Acute Post-Operative Pain for Adult Patients in the Hospital. The Medicines Company, 2015. [ cited 2015 Sep 28]. Available from: http://www.themedicinescompany.com/investors/news/medicines-company-announces-fda-approval-ionsys%C2%AE-fentanyl-iontophoretic-transdermal
- Committee for Medicinal Products for Human Use - Summary of opinion (initial authorisation). European Medicines Agency, 2015. [ cited 2015 Sep 28] Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/002715/WC500194146.pdf
- New Drugs Online Report for sumatriptan (Zecuity). UKMi New Drugs Online Database, 2015. [ cited 2015 Sep 28]. Available from: http://www.ukmi.nhs.uk/applications/ndo/record_view_open.asp?newDrugID=5533
- Park D, Park H, Seo J, et al. Sonophoresis in transdermal drug deliverys. Ultrasonics. 2014;54(1):56–65.
- A dab relieves pain of the jab. MIT News Office, 2004. [ cited 2015 Sep 28]. Available from: http://news.mit.edu/2004/sonoprep
- Arora A, Prausnitz MR, Mitragotri S. Micro-scale devices for transdermal drug delivery. Int J Pharm. 2008;364(2):227–236.
- Research Center for Biologics and Evaluation and approved products - AFLURIA. Center for Biologics Evaluation and Research, 2015. [ cited 2015 Sep 28]. Available from: http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094043.htm
- ZiNGO® product information. Marathon Pharmaceuticals LLC, 2015. [cited 2015 Sep 28]. Available from: http://marathonpharma.com/treatments/products/zingo/
- Lee JW, Gadiraju P, Park J-H, et al. Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release. 2011;154(1):58–68.
- One less painful experience - The Synera Effect. Synera (Lidocaine Tetracaine) Topical Patch, 2015. [ cited Sep 28]. Available from: http://www.synera.com/
- Donnelly RF, Majithiya R, Singh TRR, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res. 2011;28(1):41–57.
- Tuan-Mahmood TM, McCrudden MTC, Torrisi BM, et al. Microneedles for intradermal and transdermal drug delivery. Eur J Pharm Sci. 2013;50(5):623–637.
- Lohmann Therapie-Systeme AG. LTS, 2015 [ cited 2015 Oct 2]. Available from: http://www.ltslohmann.de/en/home.html
- Microneedle Drug Delivery Systems. 3M, 2015. [cited 2015 Oct 2]. Available from: http://solutions.3m.com/wps/portal/3M/en_WW/3M-DDSD/Drug-Delivery-Systems/Technologies/Microneedle
- Corium - Drug Delivery Systems. Corium, 2015. [ cited 2015 Oct 2]. Available from: http://www.coriumgroup.com/
- BD Soluvia Prefillable Microinjection System. Medical BD, 2015. [cited 2015 Oct 2]. Available from: http://www.bd.com/pharmaceuticals/products/microinjection.asp
- FDA. NanoPass’s MicronJet 600, 2010. [ cited 2015 Oct 2]. Available from: http://www.accessdata.fda.gov/cdrh_docs/pdf9/K092746.pdf
- Quinn HL, Kearney M-C, Courtenay AJ, et al. The role of microneedles for drug and vaccine delivery. Expert Opin Drug Deliv. 2014;11(11):1769–1780.
- Zosano Pharma Resumes Development of Weekly ZP-PTH Treatment for Severe Osteoporosis. Zosano Pharma, 2015. [ cited 2015 Oct 12]. Available from: http://ir.zosanopharma.com/releasedetail.cfm?ReleaseID=933481
- Vaxxas Initiates Research Project on Advancing Next Generation Technology for Polio Vaccine Delivery. Vaxxas, 2014. [ cited 2015 Oct 2]. Available from: http://www.vaxxas.com/news/vaxxas-initiates-research-project-on-advancing-next-generation-technology-for-polio-vaccine-delivery/
- BioSerenTach Inc News. BioSerenTach Inc, 2014. [ cited 2015 Oct 2]. Available from: http://www.bioserentach.co.jp/e-news.html
- Donnelly RF, Singh TRR, Garland MJ, et al. Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery. Adv Funct Mater. 2012;22(23):4879–4890.
- Donnelly RF, Woolfson AD. Patient safety and beyond: what should we expect from microneedle arrays in the transdermal delivery arena? Ther Deliv. 2014;5(6):653–662.
- McCrudden MTC, McAlister E, Courtenay AJ, et al. Microneedle applications in improving skin appearance. Exp Dermatol. 2015;24(8):561–566.
- Soltani-Arabshahi R, Wong JW, Duffy KL, et al. Facial Allergic Granulomatous Reaction and Systemic Hypersensitivity Associated With Microneedle Therapy for Skin Rejuvenation. JAMA Dermatol. 2014;150(1):68–72.
- Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268.
- Wiedersberg S, Guy RH. Transdermal drug delivery: 30+ years of war and still fighting! J Control. 2014;190:150–156.
- Walter JR, Xu S. Therapeutic transdermal drug innovation from 2000 to 2014: current status and outlook. Drug Discov Today. 2015. published online 2015 Jun 23. DOI:10.1016/j.drudis.2015.06.007
- Donnelly RF, Moffatt K, Alkilani AZ, et al. Hydrogel-Forming Microneedle Arrays Can Be Effectively Inserted in Skin by Self-Application: A Pilot Study Centred on Pharmacist Intervention and a Patient Information Leaflet. Pharm Res. 2014;31(8):1989–1999.
- Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine. 2014;32(16):1856–1862.